Woodhams et al v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.

Track this case

Case overview

Case Number:

1:18-cv-03990

Court:

New York Southern

Nature of Suit:

Contract: Other

Multi Party Litigation:

Class Action

Judge:

J. Paul Oetken

Firms

Companies

Sectors & Industries:

  1. March 22, 2024

    Robitussin Buyers' Lack Of Receipts Dooms Labeling Cert.

    A New York federal judge on Thursday denied class certification in litigation claiming GlaxoSmithKline lied about the "Maximum Strength" label on certain Robitussin cough syrup products, saying although the plaintiffs' lack of receipts does not warrant GSK's bid for summary judgment, it's enough to dismiss the customers' request for certification.

  2. November 16, 2021

    Pfizer Must Face Trimmed Robitussin Labeling Suit

    Pharmaceutical giant Pfizer won the partial dismissal of a proposed class action in New York federal court Monday accusing it of misleading consumers with its "Maximum Strength" labeling of Robitussin cough syrup, but it failed to get the suit's nationwide class allegations stricken.